Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery

L. Tamir, M. Mittelman, D. Hendel, A. Zeidman, U. Ashkenazi, A. M. Cohen, M. Fridlander, Z. Fradin

Open source

DOI
10.1163/156855900300109198
Published
2000-09-01
Container
Haematologia
Publisher
Walter de Gruyter GmbH
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1163/156855900300109198,
  title = {Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery},
  author = {L. Tamir and M. Mittelman and D. Hendel and A. Zeidman and U. Ashkenazi and A. M. Cohen and M. Fridlander and Z. Fradin},
  year = {2000},
  journal = {Haematologia},
  doi = {10.1163/156855900300109198},
  url = {https://doi.org/10.1163/156855900300109198}
}

RIS

TY  - JOUR
TI  - Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery
AU  - L. Tamir
AU  - M. Mittelman
AU  - D. Hendel
AU  - A. Zeidman
AU  - U. Ashkenazi
AU  - A. M. Cohen
AU  - M. Fridlander
AU  - Z. Fradin
PY  - 2000
JO  - Haematologia
DO  - 10.1163/156855900300109198
UR  - https://doi.org/10.1163/156855900300109198
ER  - 

APA

Tamir, L., Mittelman, M., Hendel, D., Zeidman, A., Ashkenazi, U., Cohen, A. M., Fridlander, M., & Fradin, Z. (2000). Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery. Haematologia. https://doi.org/10.1163/156855900300109198

Source records